Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;47(12):6278-6293.
doi: 10.1177/0300060519876467. Epub 2019 Nov 10.

The effects of di(2-ethylhexyl) phthalate exposure in women with polycystic ovary syndrome undergoing in vitro fertilization

Affiliations

The effects of di(2-ethylhexyl) phthalate exposure in women with polycystic ovary syndrome undergoing in vitro fertilization

Yue Jin et al. J Int Med Res. 2019 Dec.

Abstract

Objectives: Di(2-ethylhexyl) phthalate (DEHP) is a common endocrine-disrupting chemical, which has potential reproductive toxicity. This study aimed to explore the effects of DEHP exposure in women with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization.

Methods: In this case-control study, DEHP levels in follicular fluid (FF) of women with PCOS (n = 56) and controls (n = 51) were measured. The in vitro effects of DEHP exposure on primary-cultured human granulosa cells (GCs) and a steroidogenic human granulosa-like tumor cell line (KGN cells) were analyzed.

Results: Concentrations of DEHP in FF were significantly higher in women with PCOS than in controls. The clinical pregnancy rate was significantly lower in women with PCOS with high levels of DEHP than in controls. The levels of androgens produced by human GCs were significantly increased following DEHP exposure. Compared with controls, DEHP-treated human GCs and KGN cells showed significantly lower viability, cell cycle arrest, higher apoptosis, and altered expression of apoptosis-related genes.

Conclusion: Women with PCOS are exposed to increased levels of DEHP in follicles, which may be associated with pregnancy loss following in vitro fertilization. DEHP may disrupt steroid production, balance in cellular proliferation, and apoptosis in human granulosa cells.

Keywords: Polycystic ovary syndrome (PCOS); apoptosis; case-control study; di(2-ethylhexyl) phthalate (DEHP); in vitro study; steroid production.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Concentrations of DEHP in FF of women with PCOS and controls. The data are shown as mean ± SD. The red horizontal line represents the geometric mean. **P < 0.01 versus the control by Student’s t-test. DEHP, di(2-ethylhexyl) phthalate; FF, follicular fluid; PCOS, polycystic ovary syndrome.
Figure 2.
Figure 2.
Effects of DEHP on steroid production of primary-cultured human GCs and KGN cells. (a) The ratios of E2 to T and E1 to A in the supernatant of primary-culture medium. (b) mRNA expression levels of CYP19A1 and CYP17A1 in primary-cultured human GCs or KGN cells. (c) Protein expression levels of CYP19A1 and CYP17A1 in primary-cultured human GCs and KGN cells. Data are shown as mean ± SD. *P < 0.05 versus control by ANOVA, #P < 0.05, KGN DEHP versus PC DEHP by ANOVA. PC, primary-cultured human GCs; KGN, steroidogenic human granulosa-like tumor cell line; DEHP, di(2-ethylhexyl) phthalate; T, testosterone; E1, estrone; E2, estradiol; A, androsterone.
Figure 3.
Figure 3.
Effect of DEHP on viability of primary-cultured human GCs and KGN cells measured by MTT assay. Data are shown as mean ± SD. *P < 0.05 versus control by Student’s t-test. PC, primary-cultured human GCs; KGN, steroidogenic human granulosa-like tumor cell line; DEHP, di(2-ethylhexyl) phthalate.
Figure 4.
Figure 4.
Effect of DEHP on cell cycle of primary-cultured human GCs and KGN cells analyzed by flow cytometry. (a) Flow cytometry results. The vertical and horizontal axis indicate cell numbers and cell division cycle, respectively. (b) Histogram. Data are shown as mean ± SD. *P < 0.05 versus control by ANOVA, #P < 0.05, KGN DEHP versus PC DEHP group by ANOVA. PC, primary-cultured human GCs; KGN, steroidogenic human granulosa-like tumor cell line; DEHP, di(2-ethylhexyl) phthalate.
Figure 5.
Figure 5.
Effect of DEHP on cell of primary-cultured human GCs and KGN cells. (a) Annexin V flow cytometry assay was performed to analyze cell apoptosis. The vertical and horizontal axes indicate PI- and FITC-positive areas, respectively. Identified by flow cytometry, cells were divided into four sections: UL (annexin V-FITC− PI+) was representative of mechanical error; UR (annexin V-FITC+ PI+) was representative of late apoptosis or necrosis cells; LL (annexin V-FITC− PI−) was representative of living cells; LR (annexin V-FITC+ PI−) was representative of early apoptosis cells. (b) mRNA expression levels of caspase-3, caspase-7, caspase-8, caspase-9, and Bcl-2 in primary-cultured human GCs and KGN cells measured using real-time quantitative PCR. Data are shown as mean ± SD. *P < 0.05 versus control by ANOVA, #P < 0.05, KGN DEHP versus PC DEHP group by ANOVA. PI, propidium iodide; FITC, fluorescein isothiocyanate, PC, primary-cultured human GCs; KGN, steroidogenic human granulosa-like tumor cell line; DEHP, di(2-ethylhexyl) phthalate.

References

    1. Skiba MA, Islam RM, Bell RJ, et al. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2018; 24: 694–709. DOI: 10.1093/humupd/dmy022. - PubMed
    1. Li R, Zhang Q, Yang D, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 2013; 28: 2562–2569. DOI: 10.1093/humrep/det262. - PubMed
    1. Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2016; 31: 2841–2855. DOI: 10.1093/humrep/dew218. - PubMed
    1. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41. DOI: 10.1186/1741-7015-8-41. - PMC - PubMed
    1. Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016; 22: 687–708. DOI: 10.1093/humupd/dmw025. - PubMed